A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis

Carbapenem-resistant Acinetobacter baumannii (CRAB), an important nosocomial pathogen, occurs particularly in the intensive care unit (ICU). Thus, the aim of this study was to compare the efficacy and safety of documented treatment with colistin monotherapy versus colistin plus meropenem in critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Katip, Wasan, Uitrakul, Suriyon, Oberdorfer, Peninnah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599589/
https://www.ncbi.nlm.nih.gov/pubmed/32998187
http://dx.doi.org/10.3390/antibiotics9100647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599589/
https://www.ncbi.nlm.nih.gov/pubmed/32998187
http://dx.doi.org/10.3390/antibiotics9100647

Ejemplares similares